1
|
Gomathy SB, Das A, Pandit AK, Srivastava AK. Enoxaparin-induced Wunderlich syndrome in a young patient with anti-GAD 65-associated opsoclonus and limbic encephalitis: a rare complication in a rare disease. BMJ Case Rep 2021; 14:e244916. [PMID: 34620636 PMCID: PMC8499240 DOI: 10.1136/bcr-2021-244916] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/23/2021] [Indexed: 11/04/2022] Open
Abstract
Wunderlich syndrome is a rare condition characterised by acute spontaneous non-traumatic renal haemorrhage into the subcapsular and perirenal spaces. Our case of anti-GAD65-associated autoimmune encephalitis (AE), aged 30 years, developed this complication following use of enoxaparin and was managed by selective glue embolisation of subsegmental branches of right renal cortical arteries. Our case had opsoclonus as one of the clinical manifestations, which has till now been described in only two patients of this AE. This patient received all forms of induction therapies (steroids, plasmapheresis, intravenous immunoglobulin and rituximab) following which she had good improvement in her clinical condition. The good response to immunotherapy is also a point of discussion as this has been rarely associated with anti-GAD65 AE.
Collapse
Affiliation(s)
- Saranya B Gomathy
- Department of Neurology, Neurosciences Centre, All India Institute of Medical Sciences, Delhi, India
| | - Animesh Das
- Neurology, All India Institute of Medical Sciences, New Delhi, India
| | | | | |
Collapse
|
2
|
Zhao Y, Jia X, Tong X, Niu G, Wang R, Liu L, Zhou F. Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review. BMC Nephrol 2021; 22:217. [PMID: 34107924 PMCID: PMC8191094 DOI: 10.1186/s12882-021-02424-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2020] [Accepted: 06/03/2021] [Indexed: 11/17/2022] Open
Abstract
Background Spontaneous perirenal hemorrhage is relatively uncommon but may be life-threatening. There are some challenges in early diagnosis due to the lack of specific presentations. Case presentation We report a case of spontaneous perirenal hemorrhage in a newly diagnosed systemic lupus erythematosus patient who initially presented with non-specific flank pain. Weakness and unstable vital signs were noted on admission. Abdominal ultrasonography and computed tomography revealed a sizable perirenal hematoma over the left retroperitoneal cavity. Renal arteriography identified active extravasation of contrast media from a distant branch of the left renal artery, and selective embolization effectively obliterated the bleeding spot. After cessation of bleeding, the patient received intensive immunosuppressive therapy for acute kidney injury and encephalopathy due to lupus. Her mental status recovered successfully, and she was withdrawn from short-term hemodialysis. Conclusions Spontaneous perirenal hemorrhage in the condition of systemic lupus erythematosus was a rare clinical entity with life-threatening potential. Early accurate diagnosis of spontaneous renal hemorrhage requires both detailed clinical examination and radiologic studies. Interventional embolization is essential and effective for both diagnosis and treatment. A high index of suspicion is necessary to avoid missing this potentially fatal syndrome, especially in patients with an increased risk of bleeding.
Collapse
Affiliation(s)
- Youlu Zhao
- Department of Nephrology, Peking University First Hospital; Institute of Nephrology, Peking University; Key Lab of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China; Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, 100034, China
| | - Xiaoyu Jia
- Department of Nephrology, Peking University First Hospital; Institute of Nephrology, Peking University; Key Lab of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China; Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, 100034, China
| | - Xiaoqiang Tong
- Department of Interventional Vascular Surgery, Peking University First Hospital, Beijing, 100034, China
| | - Guochen Niu
- Department of Interventional Vascular Surgery, Peking University First Hospital, Beijing, 100034, China
| | - Rui Wang
- Department of Radiology, Peking University First Hospital, Beijing, 100034, China
| | - Lijun Liu
- Department of Nephrology, Peking University First Hospital; Institute of Nephrology, Peking University; Key Lab of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China; Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, 100034, China
| | - Fude Zhou
- Department of Nephrology, Peking University First Hospital; Institute of Nephrology, Peking University; Key Lab of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China; Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, 100034, China.
| |
Collapse
|